Research

Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancer

Multiplex imaging and analysis using the Enable Cloud Platform to predict TNF inhibitor response in ulcerative colitis patients

A phase 2 study of Ibrutinib as neoadjuvant therapy in patients with localized prostate cancer

A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy

Single-cell transcriptomic consensus of endothelial changes induced by matrix stiffness and the association with atherosclerosis

Graph deep learning for the characterization of tumor microenvironments from spatial protein profiles in tissue specimens

Biomarker correlates of clinical response with FLT3L/Nivo backbone treatment in the multi-cohort phase 1 PORTER platform trial in metastatic, castration-resistant prostate cancer patients

7-UP: generating in silico CODEX from a small set of immunofluorescence markers

Activating immune recognition in pancreatic ductal adenocarcinoma via autophagy inhibition, MEK blockade, and CD40 agonism